Kodiak Sciences Inc. (KOD) Stock Grade

About Kodiak Sciences Inc.'s fundamentals

Kodiak Sciences is a $5.6 billion market cap biotechnology company with no dividend yield. The company reported zero year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%, while traditional profitability metrics like P/E ratio and return on equity are not applicable given the loss position.